This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Phyllis Silver: Innovator in Autoimmune Ocular Inflammatory Disease Treatment
Introduction
Phyllis Silver is a notable inventor based in Silver Spring, MD (US). She has made significant contributions to the field of medicine, particularly in the treatment of autoimmune ocular inflammatory diseases. Her innovative work has led to the development of novel methods and drug products that target specific inflammatory pathways.
Latest Patents
Phyllis Silver holds a patent for the "Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease." This patent describes methods for administering agents that antagonize the activity of IL-17 and IL-23, which are crucial in the inflammatory processes associated with these diseases. Her work represents a significant advancement in therapeutic options for patients suffering from these conditions.
Career Highlights
Throughout her career, Phyllis has been associated with Merck Sharp & Dohme Corp., where she has been able to apply her expertise in immunology and drug development. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Phyllis has collaborated with esteemed colleagues, including Rachel R. Caspi and Van T. Tsai. These partnerships have enhanced her research efforts and contributed to the advancement of treatments for autoimmune diseases.
Conclusion
Phyllis Silver's contributions to the field of autoimmune ocular inflammatory disease treatment exemplify the impact of innovative research in medicine. Her patent and collaborative efforts highlight the importance of targeted therapies in improving patient outcomes.